Cargando…

A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1

Expansion of the polyglutamine tract in the N terminus of Ataxin-1 is the main cause of the neurodegenerative disease, spinocerebellar ataxia type 1 (SCA1). However, the C-terminal part of the protein – including its AXH domain and a phosphorylation on residue serine 776 – also plays a crucial role...

Descripción completa

Detalles Bibliográficos
Autores principales: Leysen, Seppe, Burnley, Rebecca Jane, Rodriguez, Elizabeth, Milroy, Lech-Gustav, Soini, Lorenzo, Adamski, Carolyn J., Nitschke, Larissa, Davis, Rachel, Obsil, Tomas, Brunsveld, Lucas, Crabbe, Tom, Zoghbi, Huda Yahya, Ottmann, Christian, Davis, Jeremy Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505757/
https://www.ncbi.nlm.nih.gov/pubmed/34302818
http://dx.doi.org/10.1016/j.jmb.2021.167174
_version_ 1784581603018670080
author Leysen, Seppe
Burnley, Rebecca Jane
Rodriguez, Elizabeth
Milroy, Lech-Gustav
Soini, Lorenzo
Adamski, Carolyn J.
Nitschke, Larissa
Davis, Rachel
Obsil, Tomas
Brunsveld, Lucas
Crabbe, Tom
Zoghbi, Huda Yahya
Ottmann, Christian
Davis, Jeremy Martin
author_facet Leysen, Seppe
Burnley, Rebecca Jane
Rodriguez, Elizabeth
Milroy, Lech-Gustav
Soini, Lorenzo
Adamski, Carolyn J.
Nitschke, Larissa
Davis, Rachel
Obsil, Tomas
Brunsveld, Lucas
Crabbe, Tom
Zoghbi, Huda Yahya
Ottmann, Christian
Davis, Jeremy Martin
author_sort Leysen, Seppe
collection PubMed
description Expansion of the polyglutamine tract in the N terminus of Ataxin-1 is the main cause of the neurodegenerative disease, spinocerebellar ataxia type 1 (SCA1). However, the C-terminal part of the protein – including its AXH domain and a phosphorylation on residue serine 776 – also plays a crucial role in disease development. This phosphorylation event is known to be crucial for the interaction of Ataxin-1 with the 14-3-3 adaptor proteins and has been shown to indirectly contribute to Ataxin-1 stability. Here we show that 14-3-3 also has a direct anti-aggregation or “chaperone” effect on Ataxin-1. Furthermore, we provide structural and biophysical information revealing how phosphorylated S776 in the intrinsically disordered C terminus of Ataxin-1 mediates the cytoplasmic interaction with 14-3-3 proteins. Based on these findings, we propose that 14-3-3 exerts the observed chaperone effect by interfering with Ataxin-1 dimerization through its AXH domain, reducing further self-association. The chaperone effect is particularly important in the context of SCA1, as it was previously shown that a soluble form of mutant Ataxin-1 is the major driver of pathology.
format Online
Article
Text
id pubmed-8505757
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85057572021-10-13 A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1 Leysen, Seppe Burnley, Rebecca Jane Rodriguez, Elizabeth Milroy, Lech-Gustav Soini, Lorenzo Adamski, Carolyn J. Nitschke, Larissa Davis, Rachel Obsil, Tomas Brunsveld, Lucas Crabbe, Tom Zoghbi, Huda Yahya Ottmann, Christian Davis, Jeremy Martin J Mol Biol Research Article Expansion of the polyglutamine tract in the N terminus of Ataxin-1 is the main cause of the neurodegenerative disease, spinocerebellar ataxia type 1 (SCA1). However, the C-terminal part of the protein – including its AXH domain and a phosphorylation on residue serine 776 – also plays a crucial role in disease development. This phosphorylation event is known to be crucial for the interaction of Ataxin-1 with the 14-3-3 adaptor proteins and has been shown to indirectly contribute to Ataxin-1 stability. Here we show that 14-3-3 also has a direct anti-aggregation or “chaperone” effect on Ataxin-1. Furthermore, we provide structural and biophysical information revealing how phosphorylated S776 in the intrinsically disordered C terminus of Ataxin-1 mediates the cytoplasmic interaction with 14-3-3 proteins. Based on these findings, we propose that 14-3-3 exerts the observed chaperone effect by interfering with Ataxin-1 dimerization through its AXH domain, reducing further self-association. The chaperone effect is particularly important in the context of SCA1, as it was previously shown that a soluble form of mutant Ataxin-1 is the major driver of pathology. Elsevier 2021-09-17 /pmc/articles/PMC8505757/ /pubmed/34302818 http://dx.doi.org/10.1016/j.jmb.2021.167174 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Leysen, Seppe
Burnley, Rebecca Jane
Rodriguez, Elizabeth
Milroy, Lech-Gustav
Soini, Lorenzo
Adamski, Carolyn J.
Nitschke, Larissa
Davis, Rachel
Obsil, Tomas
Brunsveld, Lucas
Crabbe, Tom
Zoghbi, Huda Yahya
Ottmann, Christian
Davis, Jeremy Martin
A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1
title A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1
title_full A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1
title_fullStr A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1
title_full_unstemmed A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1
title_short A Structural Study of the Cytoplasmic Chaperone Effect of 14-3-3 Proteins on Ataxin-1
title_sort structural study of the cytoplasmic chaperone effect of 14-3-3 proteins on ataxin-1
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505757/
https://www.ncbi.nlm.nih.gov/pubmed/34302818
http://dx.doi.org/10.1016/j.jmb.2021.167174
work_keys_str_mv AT leysenseppe astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT burnleyrebeccajane astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT rodriguezelizabeth astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT milroylechgustav astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT soinilorenzo astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT adamskicarolynj astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT nitschkelarissa astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT davisrachel astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT obsiltomas astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT brunsveldlucas astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT crabbetom astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT zoghbihudayahya astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT ottmannchristian astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT davisjeremymartin astructuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT leysenseppe structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT burnleyrebeccajane structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT rodriguezelizabeth structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT milroylechgustav structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT soinilorenzo structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT adamskicarolynj structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT nitschkelarissa structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT davisrachel structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT obsiltomas structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT brunsveldlucas structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT crabbetom structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT zoghbihudayahya structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT ottmannchristian structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1
AT davisjeremymartin structuralstudyofthecytoplasmicchaperoneeffectof1433proteinsonataxin1